Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based studyResearch in context

Summary: Background: We examined the real-world comparative safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) vs. other newer anti-glycemic medications (dipeptidyl peptidase-4 inhibitors [DPP4i], glucagon-like peptide-1 receptor agonists [GLP1a]) in patients with and without chronic kidne...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Yoko Narasaki (Dahkki), Csaba P. Kovesdy (Dahkki), Amy S. You (Dahkki), Keiichi Sumida (Dahkki), Yamini Mallisetty (Dahkki), Satya Surbhi (Dahkki), Fridtjof Thomas (Dahkki), Alpesh N. Amin (Dahkki), Elani Streja (Dahkki), Kamyar Kalantar-Zadeh (Dahkki), Connie M. Rhee (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Elsevier, 2024-08-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis